Salute e Benessere

Roche's Alecensa delivers unprecedented Phase III results for people with…

ALINA data demonstrate Alecensa reduces disease recurrence in the early setting for people with ALK-positive non-small cell lung cancer (NSCLC), building on its long-established benefit in the advanced settingAbout half of people with NSCLC experience disease recurrence following surgery, despite adjuvant chemotherapy, therefore new treatments are urgently needed to provide the best chance for cureThese data will be submitted to health authorities globallyand presented at an...
Nasdaq GlobeNewswire
01/09/2023

Metastatic Uveal Melanoma Market to Grow Rapidly by 2032, Assesses DelveInsight…

Key Takeaways from the Metastatic Uveal Melanoma Market Report Key Takeaways from the Metastatic Uveal Melanoma Market Report Discover which therapies are expected to grab the major metastatic uveal melanoma market share @Metastatic Uveal Melanoma Market Report Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and aggressive form of cancer that originates in the pigmented cells of the eye's uvea, which includes the iris, ciliary body, and choroid...
PR Newswire
31/08/2023

NANOBIOTIX to Present at the H.C. Wainwright 25th Annual Global Investment…

PARIS and CAMBRIDGE, Mass., Aug.31, 2023(GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ''Company''), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced today that Laurent Levy, co-founder of Nanobiotix and chairman of the executive board, and Bart Van Rhijn, chief financial officer, will participate in a virtual fireside chat at the H.C. Wainwright 25 thAnnual...
Nasdaq GlobeNewswire
31/08/2023

JS Global Lifestyle Optimizes Business Following Successful Spin-off

HONG KONG, Aug. 31, 2023 /PRNewswire/ -- JS Global Lifestyle Company Limited (Stock Code: 1691.HK) ("JS Global" or the "Group"), a world-leading producer of small household appliances with three major brands: Shark, Ninja and Joyoung, today announced its interim results for the six months ended 30 June 2023 (the "Period"). HONG KONG,Aug. 31, 2023/PRNewswire/ --JS Global Lifestyle Company Limited (Stock Code: 1691.HK)("JS Global" or the "Group")…
PR Newswire
31/08/2023

Valneva to Participate in Investor Conferences in the United States and Europe…

Saint-Herblain (France) , August 31 , 2023–ValnevaSE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that members of its senior leadership team are scheduled to participate in 1-on-1 meetings with institutional investors at the following investor conferences in September 2023.The Company will discuss its single-dose vaccine candidate against the chikungunya virus (VLA1553), currently under priority review by the U.S. FDA with a...
Nasdaq GlobeNewswire
31/08/2023

The Single use Bioreactors Market is projected to grow at a CAGR of ~17%, till…

Single use bioreactors offer various advantages over conventional technologies, such as ease of installation, increased efficiency of the biomanufacturing process, operational flexibility, reduced risk of cross contamination, less energy and water consumption. In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the conventional stainless-steel bioreactors, manufacturers prefer to use single use bioreactors, in order to ensure the development of…
PR Newswire
31/08/2023

Iba – Transparency Notification

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)Louvain-la-Neuve, Belgium, August 31 2023 18:00 Summary of the notificationIBA (Ion Beam Applications), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received...
Nasdaq GlobeNewswire
31/08/2023

An Overview of the Veterinary Healthcare Industry: Projected Market Size, Growth…

Noteworthy points from the Global Market Model's forecast for the veterinary healthcare market comprise: Noteworthy points from the Global Market Model's forecast for the veterinary healthcare market comprise: Gain more insights into the veterinary healthcare industry trends with a free consultation: https://bit.ly/40IIkfq The Global Market Model offers insights on the following key industry indicators for the veterinary healthcare industry - Leverage the capabilities of the...
PR Newswire
31/08/2023

The Coronary Atherectomy Devices Market Is Expected To Grow At A Rate Of More…

Addressing the Rising Demand: Battling Cardiovascular Diseases Addressing the Rising Demand: Battling Cardiovascular Diseases The escalating prevalence of cardiovascular diseases (CVDs) stands as a driving force behind the surge in demand for atherectomy devices tailored for CVD treatment. Factors such as smoking, lack of physical activity, and an unhealthy diet contribute to the increasing incidence of cardiovascular diseases globally. Startlingly, heart diseases alone caused around...
PR Newswire
31/08/2023

Transactions in Zealand Pharma shares and/or related securities by persons…

Company announcement – No. 33 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, August 31, 2023–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or...
Nasdaq GlobeNewswire
31/08/2023

Total number of shares and voting rights in Zealand Pharma at August 31, 2023

Company announcement – No. 32 / 2023 Copenhagen, Denmark, August 31, 2023–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share...
Nasdaq GlobeNewswire
31/08/2023

Bavarian Nordic Provides Update on COVID-19 Booster Vaccine Program

ABNCoV2 and the comparator vaccine demonstrated a reduced level of neutralizing antibodies against a circulating variant (Omicron XBB.1.5) in Phase 3 study.cVLP platform has proven its ability to induce strong and lasting immunity against the target virus, but Bavarian Nordic sees no commercial opportunity for the vaccine, as the platform is not suitable for quick adaptions to emerging variants.The Company will continue its dialogue with authorities on how best to leverage the learnings...
Nasdaq GlobeNewswire
31/08/2023

Leukapheresis Market worth $100 million | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148 Browse in-depth TOC on "Leukapheresis Market" 230 - Tables80 - Figures295 - Pages Leukapheresis Market Scope: In this report, the overall leukapheresis market is divided into the leukapheresis products market and the Leukopaks Market. The leukapheresis products...
PR Newswire
31/08/2023

Wound Care Market size worth USD 30.52 Billion, Globally, by 2030 at 4.61% CAGR…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=31442 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=31442 Browse in-depth TOCon" Wound Care Market " 202 - Pages 126 – Tables 37 – Figures Wound Care Market: Rising Prevalence of Chronic Wounds and Surgical Procedures Drive Growth The global Wound Care Market is witnessing remarkable growth, fueled by the increasing prevalence of chronic wounds...
PR Newswire
31/08/2023

The Nanoparticle Formulation Market is projected to grow at a CAGR of 9.4%, till…

The advancements in nanotechnology have paved the way for adoption of nanoparticles as a novel mode of drug delivery for therapeutics and vaccines. Moreover, nanoparticles have emerged as a versatile tool for biomedical imaging. However, the formulation of these complex structures is associated with various challenges, such as requirement of extensive technical expertise, high capital investment and stringent regulatory policies for their development. As a result, outsourcing has become a…
PR Newswire
31/08/2023

Scantox acquires Q&Q - strengthening its offering within bioanalytical services

Jeanet Løgsted, CEO of Scantox, comments: "Scantox embarked on an ambitious growth journey when we acquired the first two international companies last year, and we are thrilled to now expand our Group further with the acquisition of Q&Q. We welcome a company known for their solid expertise within the field of bioanalysis. This aligns perfectly with the current and future direction of Scantox, where a constant focus on the highest scientific and technical quality, as well as ethical…
PR Newswire
31/08/2023

Coloplast completes the acquisition of Kerecis

Coloplast has completed the acquisition of Kerecis, announced on July 7, 2023, after receiving approval from all relevant authorities and reaching a shareholder acceptance level of 100% The terms of the transaction and the financial assumptions stated in Coloplast's stock exchange announcement no. 03/2023 regarding the acquisition of Kerecis are unchanged. The equity capital raise related to the financing of the acquisition was completed on August 30, 2023.Kerecis will be included in the...
Nasdaq GlobeNewswire
31/08/2023

ZEISS advances cataract and corneal refractive surgical care with new workflow…

- ZEISS elevates the Cataract Workflow with the new AT ELANA® 841P trifocal intraocular lens. - ZEISS elevates the Cataract Workflow with the new AT ELANA ® 841P trifocal intraocular lens. - ZEISS Corneal Refractive Workflow to support presbyopia management. - ZEISS demonstrates hyperopia indication for SMILE pro. - New ZEISS ATLAS 500 combines corneal topography and dry eye assessment for improved decision making within the cataract and corneal...
PR Newswire
31/08/2023

Alkermes Announces Recipients of 2023 Alkermes Inspiration Grants® Program

"At Alkermes, we have come to appreciate that medicines, no matter how innovative, are only one component of comprehensive care. We created the Alkermes Inspiration Grants program to support a broad spectrum of innovative approaches to addressing educational gaps and supporting the needs of people living with serious chronic diseases, as well as their caregivers and family members. This year's recipients have shown the potential, through unique and meaningful ways, to positively impact…
PR Newswire
31/08/2023

BBS-Bioactive Bone Substitutes – Inside information: The final report of the…

BBS-Bioactive Bone Substitutes Plc, Company announcement, insider information, 31 August 2023 at 1:30 p.m. (EET)BBS-Bioactive Bone Substitutes – Inside information: The report of the additional audit received from the Notified Body The CE marking process includes two main streams: approval of the quality system and product approval.Regarding the approval of the quality system, the Notified Body has now completed the two required audits (in November 2022 and March 2023) and an...
Nasdaq GlobeNewswire
31/08/2023

LG DELIVERS 'SUSTAINABLE LIFE, JOY FOR ALL' WITH LATEST HOME SOLUTIONS AT IFA…

Inspired by a forest pathway, the LG Sustainable Village has key elements of the company's ESG strategy embedded in its design and construction, with eco-responsible materials, including recycled fabrics and mesh nets, used to minimize the structure's impact. Inspired by a forest pathway, the LG Sustainable Village has key elements of the company's ESG strategy embedded in its design and construction, with eco-responsible materials, including recycled fabrics and mesh nets, used to minimize…
PR Newswire
31/08/2023

The L'OCCITANE Group is now B Corp™ certified

What sets B Corp apart is that it measures and verifies a company's entire social and environmental performance, transparency and accountability. To achieve certification, the Group rigorously evaluated its impact on all its stakeholders – including employees, the wider community, suppliers, customers, shareholders and the environment – in its offices, factories, stores and supply chain. Using the B Corp framework, the company identified best practices to help it have an ever more ambitious…
PR Newswire
31/08/2023

Astraveus Appoints Microfluidic expert Etienne Fradet as Chief Technical Officer

Astraveus is revolutionizing the field of CGT manufacturing with its Lakhesys™ platform, an end-to-end cell foundry that uses deep process optimization and single-use, microfluidic bioprocessors to deliver better results with reduced inputs. By removing the need for large-scale infrastructure, reducing costs and processing time, and overcoming the logistical challenges associated with CGT manufacturing, Astraveus is seeking to considerably widen patient access to these life-changing therapies…
PR Newswire
31/08/2023

The BioInnovation Institute welcomes eight new companies to its Venture Lab…

Bobby Soni, Chief Business Officer at BioInnovation Institute, said:"These eight early-stage companies are a fantastic addition to BII's Venture Lab. The start-ups have been selected as they demonstrate great potential to drive the innovation of solutions to current challenges in human and planetary health. We once again look forward to supporting these start-ups by providing our knowledge, network, funding, and infrastructure to build successful companies." Bobby Soni, Chief…
PR Newswire
31/08/2023
Altri  Comunicati